Detalhe da pesquisa
1.
Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis.
Mod Pathol
; 35(12): 1775-1783, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104536
2.
Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.
Gynecol Oncol
; 166(3): 530-537, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840357
3.
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 175(3): 605-615, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30868392
4.
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Br J Cancer
; 119(9): 1067-1074, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30356126
5.
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
Ann Oncol
; 29(2): 424-430, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29190319
6.
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.
Breast Cancer Res Treat
; 168(3): 601-612, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29273955
7.
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
Gynecol Oncol
; 151(1): 69-75, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078506
8.
Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
Ann Oncol
; 28(1): 96-102, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742654
9.
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis.
Breast Cancer Res Treat
; 149(3): 587-96, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616355
10.
Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.
Breast Cancer Res Treat
; 152(2): 247-52, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041687
11.
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res Treat
; 149(2): 461-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556355
12.
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma.
Br J Cancer
; 111(3): 532-8, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24937677
13.
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).
Ann Oncol
; 25(5): 998-1004, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585721
14.
The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.
Ann Surg Oncol
; 21(12): 3924-30, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24912612
15.
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Ann Oncol
; 24(4): 931-7, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23211940
16.
Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer.
Ann Oncol
; 24(12): 2994-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114856
17.
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
Ann Oncol
; 24(1): 179-85, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22865778
18.
The prognostic role of TGF-ß signaling pathway in breast cancer patients.
Ann Oncol
; 24(2): 384-390, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23022998
19.
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854).
Breast Cancer Res Treat
; 139(2): 371-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23709090
20.
Expression of cell adhesion molecules and prognosis in breast cancer.
Br J Surg
; 100(2): 252-60, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175431